Literature DB >> 29149681

Mechanistic insight into contextual TGF-β signaling.

Ying E Zhang1.   

Abstract

Transforming growth factor-β (TGF-β) controls a wide range of cellular functions by activating both SMADs and non-SMAD pathways. In different tissue or physiological environment, cellular responses to TGF-β can be diverse, even opposite. Complex regulations at the level of ligand mobilization, receptor presentation, and the network of intracellular signal transducers afford the TGF-β pathway with versatile means to induce precise cellular responses in accordance to specific contextual demands. This article summarizes recent development in how cells manage their responses to TGF-β through ligand activation, receptor abundance, as well as SMAD-dependent and SMAD-independent mechanisms. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29149681      PMCID: PMC5949236          DOI: 10.1016/j.ceb.2017.10.001

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  50 in total

1.  Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.

Authors:  Tobias A Beyer; Alexander Weiss; Yuliya Khomchuk; Kui Huang; Abiodun A Ogunjimi; Xaralabos Varelas; Jeffrey L Wrana
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

2.  TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA.

Authors:  Matt K Lee; Cécile Pardoux; Marie C Hall; Pierre S Lee; David Warburton; Jing Qing; Susan M Smith; Rik Derynck
Journal:  EMBO J       Date:  2007-08-02       Impact factor: 11.598

3.  Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β.

Authors:  Veenu Tripathi; Katherine M Sixt; Shaojian Gao; Xuan Xu; Jing Huang; Roberto Weigert; Ming Zhou; Ying E Zhang
Journal:  Mol Cell       Date:  2016-10-13       Impact factor: 17.970

4.  USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor.

Authors:  Long Zhang; FangFang Zhou; Yvette Drabsch; Rui Gao; B Ewa Snaar-Jagalska; Craig Mickanin; Huizhe Huang; Kelly-Ann Sheppard; Jeff A Porter; Chris X Lu; Peter ten Dijke
Journal:  Nat Cell Biol       Date:  2012-06-17       Impact factor: 28.824

5.  Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation.

Authors:  Yan Liu; Heng Liu; Christoph Meyer; Jun Li; Silvio Nadalin; Alfred Königsrainer; Honglei Weng; Steven Dooley; Peter ten Dijke
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

6.  The insulin response integrates increased TGF-β signaling through Akt-induced enhancement of cell surface delivery of TGF-β receptors.

Authors:  Erine H Budi; Baby-Periyanayaki Muthusamy; Rik Derynck
Journal:  Sci Signal       Date:  2015-09-29       Impact factor: 8.192

7.  Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover.

Authors:  Gianni M Di Guglielmo; Christine Le Roy; Anne F Goodfellow; Jeffrey L Wrana
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

8.  Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3.

Authors:  Mark C Wilkes; Stephen J Murphy; Nandor Garamszegi; Edward B Leof
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

9.  The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.

Authors:  Alessandro Sorrentino; Noopur Thakur; Susanne Grimsby; Anders Marcusson; Verena von Bulow; Norbert Schuster; Shouting Zhang; Carl-Henrik Heldin; Maréne Landström
Journal:  Nat Cell Biol       Date:  2008-08-31       Impact factor: 28.824

10.  FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis.

Authors:  Feng Xie; Ke Jin; Li Shao; Yao Fan; Yifei Tu; Yihao Li; Bin Yang; Hans van Dam; Peter Ten Dijke; Honglei Weng; Steven Dooley; Shuai Wang; Junling Jia; Jin Jin; Fangfang Zhou; Long Zhang
Journal:  Nat Commun       Date:  2017-04-26       Impact factor: 14.919

View more
  26 in total

Review 1.  Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis.

Authors:  Sneha Vivekanandhan; Debabrata Mukhopadhyay
Journal:  Semin Cancer Biol       Date:  2018-02-02       Impact factor: 15.707

Review 2.  Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases.

Authors:  Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Physiol Rev       Date:  2019-04-01       Impact factor: 37.312

Review 3.  HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance.

Authors:  Yaya Wang; Diana Argiles-Castillo; Emma I Kane; Anning Zhou; Donald E Spratt
Journal:  J Cell Sci       Date:  2020-04-07       Impact factor: 5.285

4.  Gain and loss of function mutations in biological chemical reaction networks: a mathematical model with application to colorectal cancer cells.

Authors:  Sara Sommariva; Giacomo Caviglia; Michele Piana
Journal:  J Math Biol       Date:  2021-05-04       Impact factor: 2.259

Review 5.  DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis.

Authors:  Sharon K Kuss-Duerkop; Joseph A Westrich; Dohun Pyeon
Journal:  Viruses       Date:  2018-02-13       Impact factor: 5.048

6.  Endosomal signalling via exosome surface TGFβ-1.

Authors:  Ganesh Vilas Shelke; Yanan Yin; Su Chul Jang; Cecilia Lässer; Stefan Wennmalm; Hans Jürgen Hoffmann; Li Li; Yong Song Gho; Jonas Andreas Nilsson; Jan Lötvall
Journal:  J Extracell Vesicles       Date:  2019-09-20

7.  BRK phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG, and metastatic potential.

Authors:  S Miah; C A S Banks; Y Ogunbolude; E T Bagu; J M Berg; A Saraf; T T Tettey; G Hattem; G Dayebgadoh; C G Kempf; M Sardiu; S Napper; L Florens; K E Lukong; M P Washburn
Journal:  Sci Adv       Date:  2019-10-23       Impact factor: 14.136

Review 8.  LTBP4 in Health and Disease.

Authors:  Chi-Ting Su; Zsolt Urban
Journal:  Genes (Basel)       Date:  2021-05-23       Impact factor: 4.096

Review 9.  Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment.

Authors:  Franck Verrecchia; Françoise Rédini
Journal:  Front Oncol       Date:  2018-04-30       Impact factor: 6.244

Review 10.  TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer.

Authors:  Wan Hua; Peter Ten Dijke; Sarantos Kostidis; Martin Giera; Marten Hornsveld
Journal:  Cell Mol Life Sci       Date:  2019-12-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.